WebDisclosure WebDisclosure
Basculer en Français
9551 Companies
188518 Keywords
120339 Articles
100656 Press releases
Headlines Articles Press releases Neurocare Group Remove
  1. Home
  2. Companies
  3. Neurocare Group
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/21/2024 at 14:20, 1 year ago

    Neurocare Group Announces Kevin Reeder as New CFO

    Growth Strategy Chief Financial Officer Mental Health Neurocare Group Kevin Reeder
  • BRIEF

    published on 11/21/2024 at 14:20, 1 year ago

    Neurocare Group annonce la nomination de Kevin Reeder au poste de directeur financier

    Stratégie De Croissance Santé Mentale Directeur Financier Kevin Reeder Groupe Neurocare
  • PRESS RELEASE

    published on 11/21/2024 at 14:15, 1 year ago

    neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

    neurocare group AG appoints Kevin Reeder as Chief Financial Officer starting January 1st, 2025. Reeder, with an MBA from Oxford University, brings vast international investment management experience
    Chief Financial Officer Appointment Neurocare Group AG Kevin Reeder International Investment Management
    Logo of Neurocare Group
Accesswire
  • Published on 12/19/2025 at 00:00, 35 minutes ago

    LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor

  • Published on 12/18/2025 at 23:10, 1 hour 25 minutes ago

    Air T, Inc. Announces Closing of Regional Express Acquisition

  • Published on 12/18/2025 at 23:05, 1 hour 30 minutes ago

    BlackBerry Reports Third Quarter Fiscal Year 2026 Results

  • Published on 12/18/2025 at 22:45, 1 hour 50 minutes ago

    Stabilis Solutions Announces Multi-Year Marine Bunkering Agreement with Carnival Coprporation at Proposed Galveston LNG Liquefaction Facility

  • Published on 12/18/2025 at 20:50, 3 hours 45 minutes ago

    Results of AGM

View all ACCESSWIRE
EQS Group
  • Published on 12/18/2025 at 22:05, 2 hours 30 minutes ago

    Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology

  • Published on 12/18/2025 at 22:05, 2 hours 30 minutes ago

    Abivax to be Added to Nasdaq Biotechnology Index

  • Published on 12/18/2025 at 20:09, 4 hours 25 minutes ago

    EQS-Adhoc: The Grounds Real Estate Development AG: Conversion of the EUR 17 million bond issued in 2023/2024 into a hybrid bond

  • Published on 12/18/2025 at 19:30, 5 hours 5 minutes ago

    Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE EN REPONSE ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES DANS LE CADRE DE L’OFFRE PUBLIQUE DE RETRAIT

  • Published on 12/18/2025 at 19:30, 5 hours 5 minutes ago

    Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES , NOTAMMENT JURIDIQUES, FINANCIERE DE PHAST INVEST

View all EQS
Les Echos
  • Published on 12/18/2025 at 18:30, 6 hours 5 minutes ago

    Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV

  • Published on 12/18/2025 at 18:30, 6 hours 5 minutes ago

    Schneider Electric finalise l’opération d’acquisition des 35% restants du capital de sa JV existante en Inde

  • Published on 12/18/2025 at 17:45, 6 hours 50 minutes ago

    Cie du Bois Sauvage: Vernietiging eigen aandelen

  • Published on 12/18/2025 at 17:45, 6 hours 50 minutes ago

    Damartex réaffirme son éligibilité au PEA-PME

  • Published on 12/18/2025 at 17:45, 6 hours 50 minutes ago

    Cie du Bois Sauvage : Cancellation of own shares

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy